These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29797312)

  • 1. A prospective observational study of pigmented naevi changes in psoriasis patients on biologic therapy.
    Choi SD; D'Souza MI; Menzies SW; Weninger W
    Australas J Dermatol; 2019 Feb; 60(1):e14-e19. PubMed ID: 29797312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanocytic nevus count and dermoscopic features do not differ in psoriatic patients undergoing biological agent versus conventional drug therapy.
    Pirmit S; Onsun N; Su O; Ozkaya DB
    G Ital Dermatol Venereol; 2017 Apr; 152(2):126-131. PubMed ID: 28166613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Mind your Moles' study: protocol of a prospective cohort study of melanocytic naevi.
    Koh U; Janda M; Aitken JF; Duffy DL; Menzies S; Sturm RA; Schaider H; Betz-Stablein B; Prow T; Soyer HP; Green AC
    BMJ Open; 2018 Sep; 8(9):e025857. PubMed ID: 30232117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of patients at high risk for cutaneous malignant melanoma using digital dermoscopy.
    Bauer J; Blum A; Strohhäcker U; Garbe C
    Br J Dermatol; 2005 Jan; 152(1):87-92. PubMed ID: 15656806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in common melanocytic naevi after intense sun exposure: digital dermoscopic study with a 1-year follow-up.
    Dobrosavljevic D; Brasanac D; Apostolovic M; Medenica L
    Clin Exp Dermatol; 2009 Aug; 34(6):672-8. PubMed ID: 19183403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of dynamic dermoscopic features of melanoma and benign naevi by sequential digital dermoscopic imaging and total body photography in a high-risk Australian cohort.
    Nguyen J; Doolan BJ; Pan Y; Vestergaard T; Paul E; McLean C; Haskett M; Kelly J; Mar V; Chamberlain A
    Australas J Dermatol; 2023 Feb; 64(1):67-79. PubMed ID: 36652275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related prevalence of dermoscopy patterns in acquired melanocytic naevi.
    Zalaudek I; Grinschgl S; Argenziano G; Marghoob AA; Blum A; Richtig E; Wolf IH; Fink-Puches R; Kerl H; Soyer HP; Hofmann-Wellenhof R
    Br J Dermatol; 2006 Feb; 154(2):299-304. PubMed ID: 16433800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of latent tuberculosis infection in patients with moderate to severe psoriasis taking biologic therapies in a dermatologic private practice in Miami, Florida.
    Medina-Gil C; Dehesa L; Vega A; Kerdel F
    Int J Dermatol; 2015 Jul; 54(7):846-52. PubMed ID: 26108266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Super-high magnification dermoscopy can aid the differential diagnosis between melanoma and atypical naevi.
    Cinotti E; Tognetti L; Campoli M; Liso F; Cicigoi A; Cartocci A; Rossi R; Rubegni P; Perrot JL
    Clin Exp Dermatol; 2021 Oct; 46(7):1216-1222. PubMed ID: 33486758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological therapies for psoriasis: Adherence and outcome analysis from a clinical perspective.
    Ross C; Marshman G; Grillo M; Stanford T
    Australas J Dermatol; 2016 May; 57(2):137-40. PubMed ID: 25754697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis and melanocytic naevi: does the first confer a protective role against melanocyte progression to naevi?
    Balato N; Di Costanzo L; Balato A; Patruno C; Scalvenzi M; Ayala F
    Br J Dermatol; 2011 Jun; 164(6):1262-70. PubMed ID: 21574971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the dermoscopic appearance of melanocytic naevi after photochemotherapy or narrow-band ultraviolet B phototherapy.
    Kilinc Karaarslan I; Teban L; Dawid M; Tanew A; Kittler H
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):526-31. PubMed ID: 17373982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.
    Garber C; Plotnikova N; Au SC; Sorensen EP; Gottlieb A
    J Drugs Dermatol; 2015 Aug; 14(8):846-52. PubMed ID: 26267729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma risk stratification of individuals with a high-risk naevus phenotype - A pilot study.
    Rishpon A; Navarrete-Dechent C; Marghoob AA; Dusza SW; Isman G; Kose K; Halpern AC; Marchetti MA
    Australas J Dermatol; 2019 Nov; 60(4):e292-e297. PubMed ID: 30941757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermoscopic changes in melanocytic naevi in children during digital follow-up.
    Fortina AB; Zattra E; Bernardini B; Alaibac M; Peserico A
    Acta Derm Venereol; 2012 Jul; 92(4):427-9. PubMed ID: 22367216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
    Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
    Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adalimumab in the treatment of moderate-to-severe chronic plaque psoriasis in patients switching from other biologics.
    Sator P; Richter L; Saxinger W; Vasiljevic M; Stingl G
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1742-9. PubMed ID: 25665143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-Line Biologic Therapy and Obesity in Moderate-to-Severe Psoriasis: Results from the Prospective Multicenter Cohort Psobioteq.
    Assan F; Tubach F; Arlegui H; Viguier M; Beylot-Barry M; Dupuy A; Beneton N; Joly P; Jullien D; Mahé E; Paul C; Richard MA; Bachelez H; Giboin C; Chosidow O; Sbidian E;
    Dermatology; 2021; 237(3):338-346. PubMed ID: 33535213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermoscopic features of congenital acral melanocytic naevi in children: a prospective comparative and follow-up study.
    Chuah SY; Tsilika K; Chiaverini C; Fontas E; Ortonne JP; Lacour JP; Bahadoran P
    Br J Dermatol; 2015 Jan; 172(1):88-93. PubMed ID: 24931364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose Modification in Biologic Therapy for Moderate to Severe Psoriasis: A Descriptive Analysis in a Clinical Practice Setting.
    Baniandrés O; Rodríguez-Soria VJ; Romero-Jiménez RM; Suárez R
    Actas Dermosifiliogr; 2015 Sep; 106(7):569-77. PubMed ID: 25935194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.